Suppr超能文献

个性化组学对精准医学的承诺。

Promise of personalized omics to precision medicine.

机构信息

Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Wiley Interdiscip Rev Syst Biol Med. 2013 Jan-Feb;5(1):73-82. doi: 10.1002/wsbm.1198. Epub 2012 Nov 26.

Abstract

The rapid development of high-throughput technologies and computational frameworks enables the examination of biological systems in unprecedented detail. The ability to study biological phenomena at omics levels in turn is expected to lead to significant advances in personalized and precision medicine. Patients can be treated according to their own molecular characteristics. Individual omes as well as the integrated profiles of multiple omes, such as the genome, the epigenome, the transcriptome, the proteome, the metabolome, the antibodyome, and other omics information are expected to be valuable for health monitoring, preventative measures, and precision medicine. Moreover, omics technologies have the potential to transform medicine from traditional symptom-oriented diagnosis and treatment of diseases toward disease prevention and early diagnostics. We discuss here the advances and challenges in systems biology-powered personalized medicine at its current stage, as well as a prospective view of future personalized health care at the end of this review.

摘要

高通量技术和计算框架的快速发展使人们能够以前所未有的细节研究生物系统。反过来,在组学水平上研究生物现象有望推动个性化和精准医疗的重大进展。可以根据患者自身的分子特征进行治疗。个体的组学特征以及多个组学特征的综合特征,如基因组、表观基因组、转录组、蛋白质组、代谢组、抗体组和其他组学信息,有望用于健康监测、预防措施和精准医疗。此外,组学技术有可能将医学从传统的以症状为导向的疾病诊断和治疗转变为疾病预防和早期诊断。在这篇综述的结尾,我们讨论了当前阶段基于系统生物学的个性化医学的进展和挑战,以及对未来个性化医疗保健的展望。

相似文献

1
Promise of personalized omics to precision medicine.
Wiley Interdiscip Rev Syst Biol Med. 2013 Jan-Feb;5(1):73-82. doi: 10.1002/wsbm.1198. Epub 2012 Nov 26.
2
Pharmacogenomics discovery and implementation in genome-wide association studies era.
Wiley Interdiscip Rev Syst Biol Med. 2013 Jan-Feb;5(1):1-9. doi: 10.1002/wsbm.1199. Epub 2012 Nov 27.
3
Multiplex assay for multiomics advances in personalized-precision medicine.
J Immunoassay Immunochem. 2019;40(1):3-25. doi: 10.1080/15321819.2018.1562940. Epub 2019 Jan 11.
4
Systems biology: personalized medicine for the future?
Curr Opin Pharmacol. 2012 Oct;12(5):623-8. doi: 10.1016/j.coph.2012.07.011. Epub 2012 Jul 31.
5
Translational -omics: Future potential and current challenges in precision medicine.
Methods. 2018 Dec 1;151:3-11. doi: 10.1016/j.ymeth.2018.05.009. Epub 2018 May 22.
6
Towards structural systems pharmacology to study complex diseases and personalized medicine.
PLoS Comput Biol. 2014 May 15;10(5):e1003554. doi: 10.1371/journal.pcbi.1003554. eCollection 2014 May.
7
iPOP goes the world: integrated personalized Omics profiling and the road toward improved health care.
Chem Biol. 2013 May 23;20(5):660-6. doi: 10.1016/j.chembiol.2013.05.001.
10
Wellness and health omics linked to the environment: the WHOLE approach to personalized medicine.
Adv Exp Med Biol. 2014;799:1-14. doi: 10.1007/978-1-4614-8778-4_1.

引用本文的文献

1
Opportunities for a national genomic data governance framework in Australia: a systematic review.
BMC Med Ethics. 2025 Aug 14;26(1):111. doi: 10.1186/s12910-025-01273-7.
2
AI-driven precision diagnosis and treatment in Parkinson's disease: a comprehensive review and experimental analysis.
Front Aging Neurosci. 2025 Jul 28;17:1638340. doi: 10.3389/fnagi.2025.1638340. eCollection 2025.
3
Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice.
PLoS One. 2025 Aug 8;20(8):e0329737. doi: 10.1371/journal.pone.0329737. eCollection 2025.
4
Bacterial two-hybrid systems evolved: innovations for protein-protein interaction research.
J Bacteriol. 2025 Aug 21;207(8):e0012925. doi: 10.1128/jb.00129-25. Epub 2025 Aug 1.
8
Metabolomics identifies plasma biomarkers of localized radiation injury.
Sci Rep. 2025 Jan 16;15(1):2166. doi: 10.1038/s41598-025-85717-5.
10
Batch-effect correction in single-cell RNA sequencing data using JIVE.
Bioinform Adv. 2024 Sep 13;4(1):vbae134. doi: 10.1093/bioadv/vbae134. eCollection 2024.

本文引用的文献

2
In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry.
J Proteome Res. 2012 Sep 7;11(9):4567-74. doi: 10.1021/pr3003672. Epub 2012 Aug 22.
3
Quantifying your body: a how-to guide from a systems biology perspective.
Biotechnol J. 2012 Aug;7(8):980-91. doi: 10.1002/biot.201100495.
4
A public resource facilitating clinical use of genomes.
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):11920-7. doi: 10.1073/pnas.1201904109. Epub 2012 Jul 13.
5
Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells.
Nature. 2012 Jul 11;487(7406):190-5. doi: 10.1038/nature11236.
6
Complexity and the reductionism-holism debate in systems biology.
Wiley Interdiscip Rev Syst Biol Med. 2012 Sep-Oct;4(5):413-27. doi: 10.1002/wsbm.1181. Epub 2012 Jul 3.
7
A population approach to precision medicine.
Am J Prev Med. 2012 Jun;42(6):639-45. doi: 10.1016/j.amepre.2012.02.012.
9
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.
Wiley Interdiscip Rev Syst Biol Med. 2012 Jul-Aug;4(4):367-83. doi: 10.1002/wsbm.1173. Epub 2012 May 11.
10
Interplay between lipids and branched-chain amino acids in development of insulin resistance.
Cell Metab. 2012 May 2;15(5):606-14. doi: 10.1016/j.cmet.2012.01.024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验